Chemical industry – Page 60
-
PodcastAdamantane
Brian Clegg introduces a crystalline hydrocarbon that isn’t as tough as it sounds, but is the basis of a wide range of medicines
-
Business
Novartis on winter deal spree
Swiss company aims to re-stock drug pipeline with three new deals in skin, eye and cardiovascular health
-
BusinessOpening doors to innovation
Chemical companies are increasingly using specialist investment arms to nurture new ideas
-
ResearchDrug binding simulations promise to get personal
Fast, reliable new molecular dynamic simulation methods set to speed up research are under investigation by GSK
-
BusinessUS Supreme Court denies Dow tax appeal
Request to reconsider $1bn tax deduction dismissed and penalties upheld
-
NewsVolkswagen hit by another $4.3bn in penalties
Emissions cheating scandal has led to the arrest of six senior employees at the company, just as Fiat comes under fire
-
BusinessCholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
BusinessIpsen to buy Merrimack’s cancer drugs
$1bn deal covers two liposome-encapsulated formulations of approved therapies
-
BusinessTaming vaccines with chemistry
Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules
-
BusinessTakeda to buy cancer specialist Ariad
Japan’s largest drug company agrees $5.2bn deal to expand oncology portfolio and boost pipeline
-
BusinessMosaic to buy Vale Fertilizantes in $2.5bn deal
Fertiliser deal continues consolidation trend and expands Mosaic’s presence in Brazil
-
BusinessLinde–Praxair merger further consolidates industrial gases
Deal will leave just three firms controlling 85% of the global market
-
BusinessShell fined $22m for drinking water contamination
Jury rules in favour of US city of Clovis over 1,2,3-trichloropropane contamination, while rejecting punitive damages
-
BusinessIndian court revokes ban on combination drugs
Companies claim government failed to follow procedure in restricting risky medicines
-
BusinessTeva fined $520m for corruption
World’s largest generics manufacturer admits paying bribes in Russia, Ukraine and Mexico
-
-
-
BusinessDuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
-
BusinessMylan may lay off up to 3500 staff
The move forms part of the US generic firm’s restructuring efforts